Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS). - Bernbeck,B.; Bahci,S.; Meisel,R. (Klin Pädiatr, 2007)